nach oben

Erschienen in:

01.07.2018 | Clinical study

Insulin analogues differ in risk for hypoglycaemia and weight gain

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Basal insulin analogues have differing safety profiles in adults with type 2 diabetes mellitus (T2DM), with a lower risk for hypoglycaemia during treatment with insulin degludec and insulin glargine 300 U/mL, and less weight gain with insulin detemir and insulin glargine 300 U/mL, according to findings of a systematic review and meta-analysis published in Annals of Internal Medicine. …

proportion of glycosylated haemoglobin

Madenidou AV, et al. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Annals of Internal Medicine : 10 Jul 2018. Available from: URL: http://doi.org/10.7326/M18-0443

Titel: Insulin analogues differ in risk for hypoglycaemia and weight gain
Publikationsdatum: 01.07.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-49299-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Insulin analogues differ in risk for hypoglycaemia and weight gain

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Biotin

Ademetionine/escitalopram

Ceftriaxone

Heparin

Adalimumab

Pirfenidone